The contribution of CA IX to the acquisition of more advanced tumor phenotypes is supported by its association with higher tumor grades and relapse rates, relation to poorly differentiated and greatly invasive tumors, and worse overall and progression-free survival in patients [25]. This evidence concerns the gene CA9 and neoplasm.